Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
Xiaofang WangLi ZhangXiaomeng ZhangJurui LuoXuanyi WangXingxing ChenZhaozhi YangXin MeiXiaoli YuZhen ZhangXiaomao GuoZhimin ShaoJinli MaPublished in: Breast cancer research and treatment (2021)
In patients with T1-2N1 breast cancer, clinical-pathological factors including young age, histological grade 3, 2-3 positive nodes, and tumor size of 3-5 cm were identified to be predictors of a poorer LRC following mastectomy. Patients with 0-1 risk factor might consider the omission of PMRT.